Browsing: CDK4/6

Top Line: Does the addition of adjuvant ribociclib improve outcomes for patients with early breast cancer?The Study: Palbociclib, a CDK4/6…

Did you know ubiquitously prescribed proton pump inhibitors (PPIs) negatively affect the oral bioavailability of CDK4/6-inhibitors? This South Korean analysis…